Lipopolysaccharide contamination in intradermal DNA vaccination: Toxic impurity or adjuvant?
- 2 July 2009
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 390 (1) , 32-36
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behaviorPhysiology & Behavior, 2006
- A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expressionNature Medicine, 2005
- Mucosal adjuvantsVaccine, 2005
- Acute Inflammatory Response to Endotoxin in Mice and HumansClinical and Vaccine Immunology, 2005
- Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modificationsMicrobes and Infection, 2003
- Removal of Phosphate from Lipid A as a Strategy to Detoxify LipopolysaccharideShock, 2002
- The role of lipopolysaccharide in T-cell responses following DNA vaccinationVaccine, 2002
- Downstream processing of plasmid DNA for gene therapy and DNA vaccine applicationsTrends in Biotechnology, 2000
- Early events in dendritic cell maturation induced by LPSMicrobes and Infection, 1999
- Inhibitory Effect of Lipopolysaccharide on Immune Response After DNA Immunization Is Route DependentDNA and Cell Biology, 1998